| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 18/03/2019 | 23:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 18/03/2019 | 12:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 04/03/2019 | 23:30 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 22/02/2019 | 23:23 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 21/02/2019 | 22:21 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 21/02/2019 | 12:15 | GlobeNewswire Inc. | Edge Therapeutics Announces Full Year 2018 Financial Results | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 15/02/2019 | 20:35 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 15/02/2019 | 12:09 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 13/02/2019 | 17:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 25/01/2019 | 23:31 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 03/01/2019 | 14:10 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 21/12/2018 | 12:05 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 30/11/2018 | 15:39 | GlobeNewswire Inc. | Edison issues update on NetScientific (NSCI) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 26/11/2018 | 12:30 | GlobeNewswire Inc. | Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 01/11/2018 | 12:15 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 01/11/2018 | 11:00 | GlobeNewswire Inc. | Edge Therapeutics Reports Third Quarter 2018 Financial Results | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 01/08/2018 | 12:00 | GlobeNewswire Inc. | Edge Therapeutics Reports Second Quarter 2018 Financial Results | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 27/06/2018 | 22:30 | GlobeNewswire Inc. | Edge Therapeutics Announces Updated Results from Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 20/06/2018 | 22:47 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 11/06/2018 | 22:03 | Business Wire | DEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. &... | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 06/06/2018 | 18:47 | Business Wire | SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. ... | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 02/05/2018 | 15:33 | GlobeNewswire Inc. | Edge Therapeutics Reports First Quarter 2018 Financial Results | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 02/05/2018 | 15:33 | GlobeNewswire Inc. | Edge Therapeutics Announces Review of Strategic Alternatives | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 02/05/2018 | 15:06 | GlobeNewswire Inc. | Edge Shareholders: Bernstein Liebhard LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Edge Therapeut... | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 25/04/2018 | 22:35 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 25/04/2018 | 22:33 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 25/04/2018 | 19:33 | PR Newswire (US) | Edge Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Edge Therapeutics... | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 24/04/2018 | 21:27 | Business Wire | INVESTOR ALERT: Kirby McInerney LLP Announces a Securities Class Action on Behalf of Edge Therapeutics, Inc. Investors | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 29/03/2018 | 15:34 | PR Newswire (US) | Investor Alert: Kaplan Fox Announces Investigation Of Edge Therapeutics, Inc. | NASDAQ:EDGE | Edge Therapeutics, Inc. |
| 28/03/2018 | 13:00 | GlobeNewswire Inc. | Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid ... | NASDAQ:EDGE | Edge Therapeutics, Inc. |